Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Grant/Award of 1,905 NVCR shares, $21.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | NovoCure Ltd (NVCR) | Grant/Award | 1,905 | $21.2K |
| Mar 5, 2026 | NovoCure Ltd (NVCR) | Grant/Award | 40,100 | n/a |
| Mar 3, 2026 | NovoCure Ltd (NVCR) | Sale | 1,441 | $19.7K |
| Nov 4, 2025 | NovoCure Ltd (NVCR) | Tax Withholding | 752 | $9.6K |
| Jul 1, 2025 | NovoCure Ltd (NVCR) | Grant/Award | 833 | $12.6K |
| Mar 6, 2025 | NovoCure Ltd (NVCR) | Grant/Award | 54,975 | $1000.0K |
| Mar 3, 2025 | NovoCure Ltd (NVCR) | Sale | 1,162 | $23.1K |
| Nov 4, 2024 | NovoCure Ltd (NVCR) | Sale | 810 | $12.8K |
| Aug 6, 2024 | NovoCure Ltd (NVCR) | Grant/Award | 1,736 | $21.2K |
| Feb 29, 2024 | NovoCure Ltd (NVCR) | Grant/Award | 71,574 | $1.17M |